Explore more publications!

Press Releases

Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
Food pH Control Agent Market Drivers 2026-2030: Analysis of Regional Trends and Market Size
Goliath Resources Ltd. Upgrades from OTCQB to a OTCQX Listing
Food Logistics Recognizes Source Logistics Executives as 2026 Rock Stars of the Supply Chain
Selection Criteria: Identifying the Best 500kVA Industrial Diesel Generator Supplier for Heavy Industry
ViroMissile Expands Phase I IDOV-ImmuneTM Trial to U.S. Sites Following IND Clearance
Commissioner Miller Urges Texans to Practice Food Safety on Super Bowl Sunday

Commissioner Miller Urges Texans to Practice Food Safety on Super Bowl Sunday

Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks
Outlook Therapeutics Reports First Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update
Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases
Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026
Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
New York Comedy Film Festival Announces Industry Panel Lineup Exploring the Craft, Business and Culture of Comedy
Ahead of the Big Game, Signature Aviation Opens Human Trafficking Awareness Training to General Aviation Industry
Grease Management Experts Highlight Operational and Compliance Risks as Beef Tallow Use Expands in Commercial Kitchens
Natural Food Colors Market to Reach USD 2.26 Billion by 2033, Driven by Clean Label Demand and Regulatory Push - SRI
Nature Medicine Publishes Helus Pharma’s Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder
Cytokinetics Announces European Commission Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions